| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSB1900022 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2019-10-16 | 辉瑞生物制药（杭州）有限公司 | Pfizer Biologics(Hangzhou)Company Limited;GE MEDICAL SYSTEMS Trade & DEVELOPMENT(Shanghai) Co Ltd | Certificate Issued | 2019-12-27 | view |